151-165 of 2767
New Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
Clinician's RoundtableNew Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
Preparing for Parenthood in Psoriasis: Closing Gaps in Family Planning Support
On the Frontlines of PsoriasisPreparing for Parenthood in Psoriasis: Closing Gaps in Family Planning Support
Understanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
Heart MattersUnderstanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
From HCM to ATTR-CM: Rethinking Unexplained Hypertrophy
AudioAbstractsFrom HCM to ATTR-CM: Rethinking Unexplained Hypertrophy
Hallie Blevins, PhD
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
On the Frontlines of MigraineCracking the Migraine Code: How AI May Transform Diagnosis and Treatment
Ashley Baker, MSN, PMHNP
Chia-Chun Chiang, MD
Why Vaccination Strategy Matters: Evidence from COVID-19 Modeling
Clinician's RoundtableWhy Vaccination Strategy Matters: Evidence from COVID-19 Modeling
- advertisement
Improving Home BP Monitoring: Inside the AMA’s Validated Device Listing
Perspectives with the AMAImproving Home BP Monitoring: Inside the AMA’s Validated Device Listing
Alexandria May, PharmD, BCPS
Jennifer Cluett, MD
Closing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025
Heart MattersClosing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025
Laurence Sperling, MD
Eugenia Gianos, MD
Recognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
DermConsultRecognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
The Convergence"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
Brian P. McDonough, MD, FAAFP
Jean-Claude Saghbini
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
NeuroFrontiersRethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Charles Turck, PharmD, BCPS, BCCCP
Desiree Matthews, PMHNP-BC
Reconnecting With Patients: A Human-Centered Approach to Everyday Practice
Clinician's RoundtableReconnecting With Patients: A Human-Centered Approach to Everyday Practice
Michael Greenberg, MD
Ryan Quigley
- advertisement
"I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold
The Convergence"I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold
Brian P. McDonough, MD, FAAFP
Matthew Newman
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of SchizophreniaNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Brian P. McDonough, MD, FAAFP
Ahmed Makhlouf, MD
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiersUsing fMRI to Identify Early Alzheimer’s Disease Subgroups
Hamid Abuwarda, PhD, BS
